Tissue bank for human blood cell disorders
Human Blood Cell Disorders Tissue Bank
This study is creating a tissue bank of blood samples from patients with blood cell disorders so researchers can learn more about these conditions and how they compare to healthy blood cells.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Northwell Health Academic / other |
| Locations | 1 site (Manhasset, New York) |
| Trial ID | NCT00902447 on ClinicalTrials.gov |
What this trial studies
The Human Blood Cell Disorder Tissue Bank aims to create a comprehensive repository of tissue samples containing various populations of human blood cells from patients with lymphoid, myeloid, and erythroid proliferative diseases. This observational study will allow internal and external researchers to access these samples to investigate the immunologic, virologic, genetic, and molecular characteristics of both abnormal and normal blood cells. The goal is to enhance understanding of blood cell disorders and facilitate better comparisons with normal cellular counterparts.
Who should consider this trial
Good fit: Ideal candidates include patients diagnosed with lymphoid, myeloid, or erythroid proliferative diseases who can provide informed consent and contribute tissue samples.
Not a fit: Patients who are anemic with hemoglobin levels below 8.0 g/dl or those infected with HIV may not benefit from this study.
Why it matters
Potential benefit: If successful, this tissue bank could significantly advance the understanding and treatment of various blood cell disorders.
How similar studies have performed: While similar tissue banks have been established, the specific focus on human blood cell disorders may provide novel insights into these conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants or participant's Legally Authorized Representatives (LAR) must be able to understand and render voluntary, written informed consent. * Patients must be able to contribute the required amount of blood and/or tissue without compromising their well-being or care. * Participants must be willing to be contacted again for consideration of additional studies in the future, such as a blood draw or another action (e.g., bone marrow aspiration and/or biopsy) that would be done as part of their standard of care. Exclusion Criteria: * Patients who are known to be anemic, with hemoglobin \<8.0g/dl. * Patients who are known to be infected with HIV.
Where this trial is running
Manhasset, New York
- The Feinstein Institute for Medical Research — Manhasset, New York, United States (Recruiting)
Study contacts
- Principal investigator: Nicholas Chiorazzi, M.D. — Northwell Health
- Study coordinator: Yasmine Kieso, MSCR
- Email: ykieso@northwell.edu
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.